1. Repository of OAI
  2. ΑΠΟΘΕΤΗΡΙΟ "ΟΛΥΜΠΙΑΣ"
  3. Σχολή Επιστημών Υγείας
  4. Τμήμα Βιολογικών Εφαρμογών και Τεχνολογιών
  5. Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά)
Ελληνικά   English  
Please use this identifier to cite or link to this item: https://olympias.lib.uoi.gr/jspui/handle/123456789/7681
Full metadata record
DC FieldValueLanguage
dc.contributor.authorPantou, D.en
dc.contributor.authorRizou, H.en
dc.contributor.authorTsarouha, H.en
dc.contributor.authorPouli, A.en
dc.contributor.authorPapanastasiou, K.en
dc.contributor.authorStamatellou, M.en
dc.contributor.authorTrangas, T.en
dc.contributor.authorPandis, N.en
dc.contributor.authorBardi, G.en
dc.date.accessioned2015-11-24T16:33:35Z-
dc.date.available2015-11-24T16:33:35Z-
dc.identifier.issn1045-2257-
dc.identifier.urihttps://olympias.lib.uoi.gr/jspui/handle/123456789/7681-
dc.rightsDefault Licence-
dc.subjectAdulten
dc.subjectAgeden
dc.subjectAged, 80 and overen
dc.subjectChromosome Bandingen
dc.subjectChromosome Mapping/methodsen
dc.subjectChromosomes, Human, Pair 14/geneticsen
dc.subjectFemaleen
dc.subjectGene Rearrangementen
dc.subjectHumansen
dc.subjectIn Situ Hybridization, Fluorescenceen
dc.subjectInterphase/geneticsen
dc.subjectMaleen
dc.subjectMetaphase/geneticsen
dc.subjectMiddle Ageden
dc.subjectMuen
dc.titleCytogenetic manifestations of multiple myeloma heterogeneityen
heal.typejournalArticle-
heal.type.enJournal articleen
heal.type.elΆρθρο Περιοδικούel
heal.identifier.primary10.1002/gcc.20114-
heal.identifier.secondaryhttp://www.ncbi.nlm.nih.gov/pubmed/15495197-
heal.identifier.secondaryhttp://onlinelibrary.wiley.com/store/10.1002/gcc.20114/asset/20114_ftp.pdf?v=1&t=h2a38o06&s=8457d0d80019d9db307c38e072eeec4f2f2da8e4-
heal.languageen-
heal.accesscampus-
heal.recordProviderΠανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών και Τεχνολογιών. Τμήμα Βιολογικών Εφαρμογών και Τεχνολογιώνel
heal.publicationDate2005-
heal.abstractTo investigate the genetic basis of the great heterogeneity observed in the clinical behavior of multiple myeloma (MM), a combined approach of G-banding, interphase fluorescence in situ hybridization (FISH), and multicolor FISH (M-FISH) was employed to analyze 70 samples from 53 patients with MM. G-banding revealed abnormal karyotypes in 77% of the cases. The origin of 31 chromosome markers was identified or revised by M-FISH. Combined metaphase karyotypic data and interphase FISH findings, using the immunoglobulin heavy-chain (IGH), IGH/cyclin D1 gene (CCND1), and D13S319 probes, revealed chromosome abnormalities in all evaluated patients and marked inter- and intratumor cytogenetic heterogeneity in the investigated MM samples. Cytogenetically unrelated clones were detected in 26% of the cases, mostly MM evaluated at diagnosis, whereas cytogenetic clonal evolution, manifested as related clones in 20% of the cases, was associated with disease progression. Among the 14q32 rearrangements, present in 66% of the cases, at least three cytogenetic subsets could be identified: one with t(11;14), usually without 13q14 deletion; another with other IGH changes, often 13q14 deletion, and hypodiploid modal chromosome number; and a third without changes in 14q32 but with abnormalities of chromosome 17. The correlation found between cytogenetic and clinicopathologic characteristics provided support for the concept that general genomic features in conjunction with specific chromosome rearrangements define the malignant phenotype in the various subsets of MM.en
heal.journalNameGenes Chromosomes Canceren
heal.journalTypepeer reviewed-
heal.fullTextAvailabilityTRUE-
Appears in Collections:Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά)

Show simple item record
Files in This Item:
File Description SizeFormat 
Pantou-2005-Cytogenetic manifest.pdf211.24 kBAdobe PDFView/Open    Request a copy
Show simple item record  


This item is licensed under a Creative Commons License Creative Commons